학술논문
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data
Document Type
Article
Author
Source
In: International Journal of Clinical Oncology . (International Journal of Clinical Oncology, April 2024, 29(4):473-480)
Subject
Language
English
ISSN
14377772
13419625
13419625